Lauren MartinAssociateMcDermott Will & Emery Websitewww.mwe.comBlogwww.mwe.com/insightsConnectEmailTwitterLinkedIn312-984-6981 Professional Biography Lauren Martin is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Chicago office. She focuses her practice on intellectual property litigation. More Legal and Business Bylines From Lauren Martin Obviousness Only Requires Reasonable Expectation of Success of One Compound Encompassed by Broad Genus Claims - (Posted On Wednesday, July 30, 2014) Sanctions Are Appropriate for Factual Misrepresentation and Abuse of Judicial Process: Monsanto Co. v. E.I. Du Pont de Nemours & Co. - (Posted On Friday, June 27, 2014) On Remand, Federal Circuit Comes Around to Supreme Court’s Way of Thinking - (Posted On Friday, May 02, 2014) When Is Anything Really Final? Re: Copyright Infringement - (Posted On Friday, October 04, 2013) A Recall Notice Directed to “6 Hour” Energy Shots Could Constitute False Advertising - (Posted On Wednesday, November 14, 2012) Plants Found in the Wild Are Not Patentable - (Posted On Wednesday, October 03, 2012) No Independent Analysis—No Preliminary Injunction - (Posted On Thursday, April 05, 2012) Preliminary Injunctions in Patent Cases Live On - (Posted On Thursday, February 09, 2012) Copyright Infringement Suit Survives Dismissal Based on Proposed Amended Complaint - (Posted On Tuesday, September 13, 2011) Pagination Previous page ‹ Previous Page 3 Current Legal Analysis Updates to the Corporate Transparency Act's Beneficial Ownership Information Reporting Requirements by: Bryce Ellis , Keith Paul Bishop Corporate Transparency Act Enforcement Resumes with Extended Deadlines by: Kathleen M. Porter , Kiernan L. Ignacio CTA Injunction Stayed; FinCEN Extends Reporting Deadlines by: Corporate Compliance, Investigations and Defense Andrews Kurth CTA Revived: Corporate Transparency Act Injunction Lifted by Federal Court and Filing Deadlines Extended by: David E. Weiss , Virginia B. Wilson CMS Rule for CY 2026 Highlights AI, Behavioral Health, Anti-Obesity Drug Coverage, and More by: Helaine I. Fingold , Philo D. Hall Important Corporate Transparency Act Update by: Ryan A. Biller , Jeffrey M. Heller CTA Reporting Requirements Reinstated by: Evgeny Magidenko , Kevin Matz Urgent Update: Corporate Transparency Act Injunction Is Stayed and Mandatory Reporting Requirements Are Applicable to Reporting Companies as Early as January 13, 2025 by: Brian A. Haskel , Robert E. Schiappacasse Upcoming Events Jan 8 2025 Key Proposals in the CY2026 Medicare Advantage and Part D Proposed Rule Jan 8 2025 Whistleblower Protections: Navigating Health Care Employment & Labor Rights Jan 14 2025 What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025 Jan 15 2025 Healthy AI Roundtable Chicago Jan 31 2025 Mass Actions: Bankruptcies, MDLs, Class Actions & Harrington v. Purdue Feb 26 2025 MCLE Triple Play Print
